Cloning: The Ethical Dilemma

Cloning: Ethical Dilemma After the cloning of the lamb to make genetically identical mother's twin, Dolly, succeeded, the horrible prospect of cloning technology caused controversy. It can not be denied that the ability to clone livestock, even human beings, is a dramatic advance in medical progress, but this technology must be carefully considered to address ethical issues. By succeeding in cloning Dolly, cloning technology has many distinct advantages.

Biotechnology ethics involves an ethical dilemma of using biotechnology in the fields of medical research, healthcare, and industrial applications. Subjects such as cloning ethics, e-health ethics, telemedicine ethics, genetic ethics, neural ethics, sports and nutrition ethics are categorized into this category; examples of specific problems include discussion on euthanasia and reproductive rights It is included. Technical ethics treats society as a common group and does not distinguish gender, but consider the influence of technology and the influence on each sex. This is an important consideration, as some technologies have been created for birth control, abortion, fertility treatment, and specific gender including Viagra. Feminist had a great influence on the excellence and development of reproductive technology

Research in this new field holds great potential, but that has room for debate. Many moral dilemmas arise from the generation and destruction of human blastocysts, as well as the possibility of cloning the entire human (reproductive clone). Many things can be learned through careful and thoughtful research, regardless of where society identifies the boundaries of research or whether stem cells can meet our high expectations. Embryonic stem cells are completely derived from fertilized eggs, and fertilized eggs grow in vitro for 5-6 days to form blastocysts. Within the blastocyst, there is a small group of about 30 cells called the inner cell mass, which will produce hundreds of highly specialized cells necessary to make adult organisms. Obtain embryonic stem cells from inner cell mass

However, human artificial pluripotent stem cells (iPS) cells, first developed in 2007, provide a promising alternative to relying on embryo destruction: the ethical dilemma brought about by the Institute of Biomedical Research There seems to be a way to overcome it. However, cloning research continues even after this discovery, and many scientists and ethicists do not know which type of cells will ultimately appear, so iPS cells clone or other forms of E I believe it can not replace S cell research. Ideal for research and treatment